Clinical Trials List
Protocol NumberCPDR001X2X01B
Active
2019-08-01 - 2030-04-30
Phase I
Recruiting1
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Yu-Chieh Tsai 無
- Chong-Jen Yu 無
- JIN-YUAN SHIH 無
- MING YAO 無
- Jih-Hsiang Lee 無
- HUAI-CHENG HUANG 無
- 徐偉勛 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
100 participants
